Timing of operation in asymptomatic severe aortic stenosis

References

• Supino PG, Borer JS, Yin A, Dillingham E, McClymont W. The epidemiology of valvular heart diseases: the problem is growing. Adv. Cardiol.41, 9–15 (2004).
   PubMed Web of Science ®Google Scholar
• Nkomo VT, Gardin JM, Skelton TN et al. Burden of valvular heart diseases: a population-based study. Lancet368(9540), 1005–1011 (2006).
   PubMed Web of Science ®Google Scholar
• Hughes GH, Cutter G, Donahue R et al. Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) Study. Control. Clin. Trials8(Suppl. 4), 68S–73S (1987).
   PubMedGoogle Scholar
• The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am. J. Epidemiol.129(4), 687–702 (1989).
   PubMed Web of Science ®Google Scholar
• Fried LP, Borhani NO, Enright P et al. The Cardiovascular Health Study: design and rationale. Ann. Epidemiol.1(3), 263–276 (1991).
   PubMedGoogle Scholar
• Rajamannan NM. Calcific aortic stenosis: a disease ready for prime time. Circulation114(19), 2007–2009 (2006).
   PubMedGoogle Scholar
• Garg V, Muth AN, Ransom JF et al. Mutations in NOTCH1 cause aortic valve disease. Nature437(7056), 270–274 (2005).
   PubMed Web of Science ®Google Scholar
• Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation101(21), 2497–2502 (2000).
   PubMed Web of Science ®Google Scholar
• Katz R, Wong ND, Kronmal R et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation113(17), 2113–2119 (2006).
   PubMed Web of Science ®Google Scholar
• Briand M, Lemieux I, Dumesnil JG et al. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J. Am. Coll. Cardiol.47(11), 2229–2236 (2006).
   PubMed Web of Science ®Google Scholar
• Messika-Zeitoun D, Bielak LF, Peyser PA et al. Aortic valve calcification: determinants and progression in the population. Arterioscler. Thromb. Vasc. Biol.27(3), 642–648 (2007).
   PubMed Web of Science ®Google Scholar
• Roger VL, Tajik AJ, Reeder GS et al. Effect of Doppler echocardiography on utilization of hemodynamic cardiac catheterization in the preoperative evaluation of aortic stenosis. Mayo Clin. Proc.71(2), 141–149 (1996).
   PubMedGoogle Scholar
• Omran H, Schmidt H, Hackenbroch M et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet361(9365), 1241–1246 (2003).
   PubMed Web of Science ®Google Scholar
• Ross J Jr, Braunwald E. Aortic stenosis. Circulation38(Suppl. 1), 61–67 (1968).
   PubMed Web of Science ®Google Scholar
• Kennedy KD, Nishimura RA, Holmes DR Jr, Bailey KR. Natural history of moderate aortic stenosis. J. Am. Coll. Cardiol.17(2), 313–319 (1991).
   PubMed Web of Science ®Google Scholar
• Bonow RO. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J. Am. Coll. Cardiol.48(5), 1486–1588 (2006).
   Google Scholar
• Otto CM, Burwash IG, Legget ME et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation95(9), 2262–2270 (1997).
   PubMed Web of Science ®Google Scholar
• Rosenhek R, Binder T, Porenta G et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N. Engl. J. Med.343(9), 611–617 (2000).
   PubMed Web of Science ®Google Scholar
• Kelly TA, Rothbart RM, Cooper CM et al. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am. J. Cardiol.61(1), 123–130 (1988).
   PubMed Web of Science ®Google Scholar
• Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J. Am. Coll. Cardiol.15(5), 1012–1017 (1990).
   PubMed Web of Science ®Google Scholar
• Pellikka PA, Sarano ME, Nishimura RA et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation111(24), 3290–3295 (2005).
   PubMed Web of Science ®Google Scholar
• Amato MC, Moffa PJ, Werner KE, Ramires JA. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart86(4), 381–386 (2001).
   PubMed Web of Science ®Google Scholar
• Chizner MA, Pearle DL, deLeon AC Jr. The natural history of aortic stenosis in adults. Am. Heart J.99(4), 419–424 (1980).
   PubMed Web of Science ®Google Scholar
• Pai RG, Kapoor N, Bansal RC, Varadarajan P. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann. Thorac. Surg.82(6), 2116–2122 (2006).
   PubMed Web of Science ®Google Scholar
• Messika-Zeitoun D, Aubry MC, Detaint D et al. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation110(3), 356–362 (2004).
   PubMed Web of Science ®Google Scholar
• Alborino D, Hoffmann JL, Fournet PC, Bloch A. Value of exercise testing to evaluate the indication for surgery in asymptomatic patients with valvular aortic stenosis. J. Heart Valve Dis.11(2), 204–209 (2002).
   PubMedGoogle Scholar
• Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur. Heart J.26(13), 1309–1313 (2005).
   PubMed Web of Science ®Google Scholar
• Bergler-Klein J, Klaar U, Heger M et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation109(19), 2302–2308 (2004).
   PubMed Web of Science ®Google Scholar
• Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation115(22), 2856–2864 (2007).
   PubMed Web of Science ®Google Scholar
• Rosenhek R, Rader F, Loho N et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation1291–1295 (2004).
   PubMedGoogle Scholar
• Cowell SJ, Newby DE, Prescott RJ et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N. Engl. J. Med.352(23), 2389–2397 (2005).
   PubMed Web of Science ®Google Scholar
• Moura LM, Ramos SF, Zamorano JL et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J. Am. Coll. Cardiol.49(5), 554–561 (2007).
   PubMed Web of Science ®Google Scholar
• Rossebo AB, Pedersen TR, Allen C et al. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am. J. Cardiol.99(7), 970–973 (2007).
   PubMed Web of Science ®Google Scholar
• Chan KL, Teo K, Tam J, Dumesnil JG. Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial. Am. Heart J.153(6), 925–931 (2007).
   PubMed Web of Science ®Google Scholar
• O’Brien KD. Do bioprosthetic aortic valves deteriorate more rapidly in patients with the metabolic syndrome? Nat. Clin. Pract. Cardiovasc. Med.4, 192–193 (2007).
   PubMedGoogle Scholar
• O’Brien KD, Probstfield JL, Caulfield MT et al. Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch. Int. Med.165(8), 858–862 (2005).
   PubMedGoogle Scholar
• O’Brien KD, Shavelle DM, Caulfield MT et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation106(17), 2224–2230 (2002).
   PubMed Web of Science ®Google Scholar
• Braunwald E. On the natural history of severe aortic stenosis. J. Am. Coll. Cardiol.15(5), 1018–1020 (1990).
   PubMed Web of Science ®Google Scholar
• Jamieson WRE, Edwards FH, Schwartz M et al. Risk stratification for cardiac valve replacement. National Cardiac Surgery Database. Ann. Thorac. Surg.67(4), 943–951 (1999).
   PubMed Web of Science ®Google Scholar
• Smith WTt, Ferguson TB Jr, Ryan T, Landolfo CK, Peterson ED. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J. Am. Coll. Cardiol.44(6), 1241–1247 (2004).
   PubMed Web of Science ®Google Scholar
• Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J.28(2), 230–268 (2007).
   PubMed Web of Science ®Google Scholar
• Malouf JF, Enriquez-Sarano M, Pellikka PA et al. Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. J. Am. Coll. Cardiol.40(4), 789–795 (2002).
   PubMed Web of Science ®Google Scholar
• Webb JG, Chandavimol M, Thompson CR et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation113(6), 842–850 (2006).
   PubMed Web of Science ®Google Scholar